2021 CMS PFS

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

Groove

Member
Lifetime Donor
20+ Year Member
Joined
May 3, 2004
Messages
3,487
Reaction score
4,138
Anyone able to clarify what this part means:

"Scope of Practice: CMS is proposing to allow nurse practitioners (NPs), clinical nurse specialists (CNSs), physician assistants (PAs) and certified nurse-midwives (CNMs) to supervise the performance of diagnostic tests in addition to physicians. CMS granted this flexibility during the COVID-19 PHE and is now proposing to extend it permanently. CMS is concerned about ensuring an adequate workforce is areas where there are shortages and seeks information about states that have scope of practice laws in place"

And this is directly from the CMS document:

"In light of stakeholder feedback to CMS on identifying additional Medicare regulations that contain more restrictive supervision requirements than existing state scope of practice laws, or that limit health professionals from practicing at the top of their license, effective January 1, 2021, we are proposing to amend the basic rule under the regulation at § 410.32(b)(1) to allow NPs, CNSs, PAs or CNMs to supervise diagnostic tests on a permanent basis as allowed by state law and scope of practice.

We are proposing to amend the regulation at § 410.32(b)(2)(iii)(B) on a permanent basis to specify that supervision of diagnostic psychological and neuropsychological testing services can be done by NPs, CNS’s, PAs or CNMs to the extent that they are authorized to perform the tests under applicable State law and scope of practice, in addition to physicians and CPs who are currently authorized to supervise these tests. We are also proposing to amend on a permanent basis, the regulation at § 410.32 to add paragraph (b)(2)(ix) to specify that diagnostic tests performed by a PA in accordance with their scope of practice and State law do not require the specified level of supervision assigned to individual tests, because the relationship of PAs with physicians under § 410.74 would continue to apply. We are also proposing to make permanent the removal of the parenthetical, previously made as part of the May 1, 2020 COVID-19 IFC (85 FR 27550 through 27629), at § 410.32(b)(3) that required a general level of physician supervision for diagnostic tests performed by a PA."

i.e. allowing full scope of practice without supervision? Or something else I'm not understanding?
 
Last edited:
Anyone able to clarify what this part means:

"Scope of Practice: CMS is proposing to allow nurse practitioners (NPs), clinical nurse specialists (CNSs), physician assistants (PAs) and certified nurse-midwives (CNMs) to supervise the performance of diagnostic tests in addition to physicians. CMS granted this flexibility during the COVID-19 PHE and is now proposing to extend it permanently. CMS is concerned about ensuring an adequate workforce is areas where there are shortages and seeks information about states that have scope of practice laws in place"

i.e. allowing full scope of practice without supervision? Or something else I'm not understanding?
Considering mid-levels have been able to order diagnostic tests in the ED for a long time, I'm not sure what application the "supervision of the performance of diagnostic tests" would have to emergency medicine. But it does sound like an expansion of the scope of practice of mid-levels, perhaps more relevant to other specialties. Here's one example I found that relates to pulmonology,

"Many are surprised to find a test like spirometry with bronchodilation responsiveness, code 94060, requires direct supervision. Which means the physician must be present in the suite when the test is performed."
 
Sounds like taking over the job of the pathologist or whoever runs the lab and is responsible for making sure everything is accurate.
 
Top